Lipoprotein(a) in neoplastic transformation

Area of Science:

• Oncology
• Cardiovascular Medicine
• Biochemistry

Background:

• Cardiovascular diseases and cancer are leading global causes of mortality.
• Shared risk factors and treatment modalities exist between cardiovascular diseases and cancer.
• Dyslipidemia is implicated in both disease types, but its precise roles remain under investigation.

Purpose of the Study:

• To review current research on the association between plasma lipoprotein(a) levels and cancer risk.
• To explore potential biological mechanisms linking lipoprotein(a) to cancer.
• To enhance the understanding of lipoprotein(a)'s role in oncogenesis.

Main Methods:

• Comprehensive literature search of recent studies.
• Synthesis of evidence on lipoprotein(a) and various cancer types.
• Analysis of proposed molecular pathways and mechanisms.

Main Results:

• Growing evidence suggests a correlation between elevated lipoprotein(a) and increased risk for certain cancers.
• Potential mechanisms include inflammation, lipid metabolism disruption, and pro-thrombotic effects.
• Lipoprotein(a) may influence tumor growth, progression, and metastasis.

Conclusions:

• Lipoprotein(a) emerges as a potential biomarker and therapeutic target in oncology.
• Further research is warranted to elucidate the causal relationship and clinical implications.
• Understanding lipoprotein(a)'s role could lead to novel strategies for cancer prevention and treatment.